Cart 0
In the UK, medical cannabis treatment follows a two-step process involving specialists and GPs. Specialists, registered with the GMC, issue the initial prescription after evaluating a patient’s eligibility and creating a treatment plan. GPs then manage repeat prescriptions, monitor progress, and adjust dosages under the specialist’s guidance.
- Specialists: Handle initial assessments and prescribe cannabis-based medicinal products (CBMPs). They focus on complex cases and create tailored treatment plans.
- GPs: Take over follow-up care, track treatment results, adjust dosages, and manage side effects. They work within shared care agreements with specialists.
This system aims to balance access to treatment with specialist oversight. However, challenges include the limited number of specialists prescribing cannabis (0.25% of 95,000). With 70,000 GPs available, their involvement helps reduce waiting times and ensures continuity of care. Private clinics, like Elios Clinics, often initiate treatment, with GPs stepping in for long-term management.
Quick Comparison:
| Role | Specialists | GPs |
|---|---|---|
| Prescriptions | Issue initial cannabis prescriptions | Manage repeat prescriptions after approval |
| Focus | Complex assessments, treatment planning | Monitoring, dosage adjustments, side effects |
| Settings | NHS and private clinics | Local GP practices |
This collaborative approach ensures patients receive expert-led care initially and ongoing support locally.
Goodfellow Unit Webinar: Medicinal cannabis and how to prescribe
Who Can Prescribe Medical Cannabis in the UK?
The UK has strict rules about who can prescribe medical cannabis, as well as under what circumstances and conditions. These regulations play a key role in determining how quickly patients can access treatment and who will oversee their care. This framework shapes the distinct responsibilities of specialists and GPs in managing patient treatment.
Specialists and Initial Prescriptions
In the UK, only specialists registered with the General Medical Council (GMC) are allowed to issue the first prescription for cannabis-based medicinal products (CBMPs). This requirement distinguishes the UK from countries such as Germany, where GPs have more authority to prescribe these treatments from the outset. However, the reliance on specialists creates challenges. Appointments can be hard to secure, and waiting times are often lengthy. As a result, most initial prescriptions are issued by private medical cannabis clinics rather than through NHS services. For example, Elios Clinics, which employs GMC-approved specialists, offers direct appointments without requiring a GP referral for conditions like chronic pain, psychiatric disorders, and neurological issues. Once the treatment is initiated by a specialist, GPs take over the responsibility for ongoing care.
GPs and Ongoing Care
GPs play a supporting role by managing repeat prescriptions after a specialist has established a treatment plan. This division of responsibilities helps relieve the pressure on the limited number of specialists while ensuring patients receive consistent care. With over 70,000 GPs practising in the UK, their involvement enables follow-up appointments to monitor treatment progress, adjust dosages, and manage any side effects. Some GPs have expressed optimism about potential future legal changes that could grant them more authority to prescribe medical cannabis, which might improve patient access to these treatments.
NHS vs Private Clinics
Although GMC-registered specialists can prescribe medical cannabis in both NHS and private settings, the actual pathways for accessing treatment differ significantly. Private clinics, like Elios Clinics, rely on specialist teams for initial assessments and prescriptions, while GPs manage repeat prescriptions under shared care agreements.
Both NHS and private clinics operate under strict regulatory frameworks. Specialists prescribing medical cannabis must be registered with the GMC, and private clinics must meet standards set by the Care Quality Commission (CQC), as well as comply with Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and UK laws on controlled substances.
In practice, patients often begin their journey in private clinics for their initial assessment and prescription. Later, their NHS GP may step in to handle repeat prescriptions and provide ongoing monitoring under shared care arrangements. This blended approach aims to combine specialist expertise with the accessibility of GP services, ensuring patients receive comprehensive care.
Specialists: Initial Assessment and Treatment Planning
Specialists play a key role in determining whether medical cannabis is suitable for a patient and in creating a treatment plan tailored to individual needs. This initial phase involves careful evaluation to ensure both safety and effectiveness.
Assessing Patient Eligibility
The journey begins with a detailed review of the patient’s medical history. Specialists look at past illnesses, surgeries, current medications, and lifestyle factors to build a complete health profile. During the first consultation, they verify the patient’s identity and confirm eligibility under UK regulations. This process includes a thorough discussion of symptoms, exploring how cannabis might help and considering any potential interactions with existing conditions.
For instance, at Elios Clinics, specialist doctors conduct in-depth consultations to confirm eligibility, particularly when conventional treatments have not provided relief.
This assessment helps identify any contraindications or drug interactions before treatment begins. Specialists also stay informed about UK medical cannabis laws and prescribing guidelines, ensuring they take full responsibility for the initial prescription decision.
Designing Personalised Treatment Plans
Once eligibility is confirmed, specialists use their expertise to recommend the most suitable cannabis products, dosages, and methods of administration. This personalised approach stands in contrast to generic treatment methods.
Specialists rely on up-to-date knowledge about cannabis strains, cannabinoid profiles, and associated benefits and risks. They take into account factors such as symptom severity, responses to previous medications, and possible drug interactions when crafting a treatment plan.
Treatment plans are designed to balance effectiveness with safety. Typically, dosages start low and are adjusted gradually based on the patient’s response, reducing the risk of side effects while identifying the most effective dose. Specialists work closely with patients to set realistic treatment goals, whether it’s managing pain or reducing dependency on opioids. These personalised plans also assist GPs during follow-ups, ensuring seamless care.
At Elios Clinics, specialists focus on creating tailored prescriptions. This includes selecting the right strain and dosage, providing guidance on proper usage, and monitoring symptoms. Patients are fully informed about the potential benefits and risks, empowering them to make confident decisions about their treatment.
Treating Complex Medical Conditions
Specialists are particularly valuable when treating patients with complex medical histories or multiple conditions. They handle challenging cases such as chronic pain, psychiatric disorders (like anxiety, depression, and PTSD), and neurological conditions (including multiple sclerosis and epilepsy).
For these patients, a specialist’s assessment is essential to evaluate how cannabis might interact with existing medications. If cannabis treatment is deemed unsuitable, specialists clearly explain their reasoning and suggest alternative therapies.
Beyond prescribing, specialists collaborate with nurses and pharmacists to ensure thorough evaluations. They maintain detailed records to guarantee continuity of care and to support GPs during follow-up treatments.
The consultation process is carefully structured and documented, ensuring each treatment plan is tailored, effective, and compliant with regulations. Specialists also engage in ongoing professional development to stay current with advancements in medical cannabis research and its applications.
This comprehensive approach ensures that GPs can confidently manage follow-up care, building on the groundwork laid by specialists.
GPs: Follow-Up Care and Patient Monitoring
Once a specialist initiates treatment, GPs take on the role of monitoring the patient’s progress to ensure the therapy remains safe, effective, and tailored to the individual’s needs.
Tracking Treatment Results
After the specialist’s initial assessment, regular follow-up appointments with GPs are essential. These consultations allow GPs to evaluate how well the treatment is working, focusing on the symptoms that were most problematic at the start and tracking any changes. GPs also review whether dosage adjustments or routine modifications are needed, addressing side effects promptly to maintain the patient’s comfort and trust.
At Elios Clinics, specialist clinicians arrange follow-up appointments to guide patients on how to use cannabis effectively. They work closely with GPs and other healthcare providers, ensuring any questions about patient care are addressed quickly and efficiently.
Adjusting Dosages and Managing Side Effects
GPs play a key role in fine-tuning treatment by adjusting doses and administration methods based on patient response. During check-ins, they discuss whether dosage changes are needed to improve outcomes. If side effects arise, GPs may adapt the treatment plan by lowering the dose, changing the timing, or exploring different formulations to strike a balance between effectiveness and tolerance. For persistent or serious adverse reactions, GPs reassess the treatment approach, explore alternative options, or recommend seeking a second opinion. This dynamic process highlights the collaborative care model between GPs and specialists.
Building Patient Relationships and Providing Comprehensive Care
The relationship between a GP and their patient is central to successful follow-up care. Regular appointments provide a space for open discussions about treatment progress and any concerns, fostering trust and encouraging candid feedback. Beyond monitoring cannabis treatment, GPs offer broader healthcare support, connecting patients with additional services and addressing other medical needs.
This collaborative approach also has practical advantages. By working within a shared care model, GPs can make dosage adjustments under specialist guidance, helping to minimise waiting times and avoid treatment interruptions. For more complex cases, GPs escalate concerns to specialists or explore alternative care options, ensuring patients receive the support they need.
sbb-itb-24979b8
How GPs and Specialists Work Together
After specialists conduct assessments and GPs handle follow-ups, collaboration between the two becomes essential for achieving the best treatment outcomes. This teamwork ensures patients benefit from expert evaluations while continuing to receive accessible, ongoing care from their local GP.
Shared Care Agreements
Shared care agreements are key to coordinating cannabis treatment. These formal arrangements allow specialists to initiate treatment while GPs take over responsibilities like monitoring patients and issuing repeat prescriptions. Although only a small number of specialists issue initial prescriptions, these agreements clearly outline roles for tasks such as initial assessments, adjusting dosages, monitoring side effects, and renewing prescriptions.
By dividing responsibilities, shared care agreements let specialists focus on more complex cases, while GPs manage routine follow-ups. Specialists provide GPs with detailed information, including assessment results, treatment plans, dosage guidelines, and monitoring instructions. They also offer clear advice on when GPs should escalate concerns.
At Elios Clinics, specialist clinicians work closely with GPs and other healthcare professionals to ensure continuity of care. This collaboration helps reduce waiting times and prevents interruptions in treatment. The structured approach creates a seamless partnership between cannabis clinics and local healthcare providers.
Multidisciplinary Teams in Cannabis Clinics
Many cannabis clinics now rely on multidisciplinary teams, which include specialists, GPs, nurses, and pharmacists. Each member brings their expertise to provide well-rounded care, addressing cannabis treatment as well as other health issues that may arise during follow-ups.
In these teams, specialists focus on diagnosing and planning treatment for complex cases, while GPs ensure ongoing care and take a broader view of the patient’s overall health. Nurses play a crucial role in offering clinical support and educating patients, and pharmacists bring their knowledge of medication management. Regular team discussions help ensure patient care is safe and effective.
Improving Patient Access and Reducing Specialist Workload
Shared care agreements and multidisciplinary teamwork together improve access to treatment while easing the burden on specialists. By involving the UK’s 70,000 GPs in monitoring and issuing repeat prescriptions, more patients can be supported. This division of labour allows specialists to dedicate their time to complex cases, leaving GPs to handle routine care.
This approach reduces waiting times, prevents treatment delays, and ensures patients receive consistent care. Specialists evaluate whether patients are suitable for GP-led follow-ups by considering factors like treatment stability, medical complexity, and patient reliability. Those with straightforward needs can receive care closer to home, while complex cases remain under specialist supervision.
Additionally, this collaborative model helps tackle practical challenges, such as appointment backlogs, enabling quicker care and timely dose adjustments. However, for GPs to confidently participate, proper training and ongoing support are essential. Organisations like the Medical Cannabis Clinicians Society provide education on cannabis pharmacology, patient assessments, dosage management, and recognising side effects. With continued guidance from clinic specialists, GPs can access expert advice when needed, helping to grow the network of professionals equipped to deliver this evolving treatment.
Comparing GPs and Specialists in Cannabis Care
In the realm of cannabis care, GPs and specialists play distinct yet interconnected roles. Specialists typically handle the initial, more complex assessments, while GPs manage routine follow-ups and ongoing care. This division creates a collaborative system where specialists focus on detailed evaluations, and GPs ensure accessible, long-term support.
GPs vs Specialists: Key Differences
Specialists are responsible for conducting comprehensive initial assessments and crafting tailored treatment plans. On the other hand, GPs provide continuity by monitoring patient progress, adjusting treatments, and ensuring consistent care within the framework set by specialists.
| Aspect | Specialists | GPs |
|---|---|---|
| Prescribing Authority | Issue initial prescriptions for cannabis treatment. | Cannot issue initial prescriptions but can manage repeat prescriptions and follow-up care after specialist approval. |
| Assessment Focus | Perform in-depth initial evaluations, reviewing medical history, symptoms, and clinical presentation to determine suitability for treatment. | Monitor treatment outcomes, assess progress, and discuss symptom improvement and medication adjustments. |
| Treatment Planning | Develop personalised treatment strategies, including dosage, administration methods, and product recommendations. | Modify existing plans based on patient response, addressing side effects or changing dosages as needed. |
| Patient Conditions | Handle complex cases requiring detailed initial evaluation and treatment planning. | Manage ongoing care for patients, focusing on stability and consistency within the treatment framework. |
| Consultation Focus | Provide thorough consultations to establish treatment plans and evaluate patient suitability in detail. | Conduct regular check-ins to track progress, review symptoms, and maintain trust through consistent care. |
| Escalation Pathways | Reassess and manage cases where treatment complications or failures occur, requiring further specialist intervention. | Identify issues like serious side effects and refer patients back to specialists when necessary for further evaluation. |
This structured approach highlights the complementary roles of GPs and specialists in cannabis care.
The UK’s regulatory framework enforces a two-tier system: specialists hold exclusive authority to issue initial prescriptions, while GPs are integral to managing repeat prescriptions and follow-up care. With over 70,000 GPs practising across the UK, their involvement in ongoing care helps alleviate pressure on the smaller pool of specialists.
This division of responsibilities allows specialists to dedicate their time to complex, initial evaluations, while GPs focus on monitoring and refining treatment plans. Many patients report improvements during follow-up appointments with their GP, showing that this collaborative model ensures effective care, reduces specialist waiting times, and minimises treatment disruptions.
Conclusion
The UK’s medical cannabis care system thrives on a collaborative effort between specialists and GPs, with each playing a distinct but interconnected role. Specialists handle the crucial first steps – evaluating patient eligibility and crafting tailored treatment plans. Their expertise in cannabis pharmacology and complex medical conditions is central to ensuring that patients receive the right care from the outset. GPs, on the other hand, take charge of the long-term aspects: monitoring progress, issuing repeat prescriptions, and fine-tuning treatments based on patient feedback. This approach ensures continuity of care while allowing specialists to focus on complex cases.
This division of responsibilities tackles a pressing challenge in the UK’s healthcare system. With over 70,000 practising GPs available to oversee follow-up care, the system mitigates the impact of limited specialist prescribers. It reduces waiting times, minimises interruptions in treatment, and ensures that specialists can dedicate their time to initial assessments and more intricate cases.
Once specialists complete the initial evaluations, GPs step in to maintain care continuity. Through regular appointments, they monitor symptom changes, catch potential side effects early, and adjust dosages when needed. This ongoing interaction not only strengthens the doctor-patient relationship but also provides a platform to address other health concerns that could influence treatment outcomes. If complications arise, GPs can modify the treatment plan or refer patients back to specialists, ensuring patient safety remains the top priority.
At Elios Clinics, this collaborative model is put into action. Specialist clinicians work closely with patients’ GPs and other healthcare professionals. This teamwork ensures that GPs are supported in managing medical cannabis care while maintaining the necessary specialist oversight. The result is a well-rounded approach to treating chronic pain, psychiatric conditions, and neurological disorders with medical cannabis.
The partnership between specialists and GPs exemplifies the potential of accessible, patient-centred care. This collaboration is essential for delivering safe, effective, and balanced medical cannabis treatment across the UK’s healthcare system. Together, they provide a framework that prioritises both expertise and accessibility, ensuring the best outcomes for patients.
FAQs
Why do specialists need to issue the first prescription for medical cannabis in the UK?
In the UK, medical cannabis is categorised as a Schedule 2 controlled drug, meaning its use is tightly regulated. According to current rules, the first prescription must come from a specialist doctor registered on the General Medical Council (GMC) Specialist Register. This ensures patients undergo a thorough evaluation and that the treatment aligns with their specific medical needs.
Specialist doctors are equipped to handle complex medical histories and decide if medical cannabis is a suitable option. After the initial prescription, ongoing care can often be coordinated with a general practitioner, depending on the patient’s individual circumstances and treatment plan.
What are the benefits of shared care agreements between GPs and specialists for medical cannabis treatment?
Shared care agreements between GPs and specialists play a vital role in providing patients undergoing medical cannabis treatment with consistent and well-coordinated care. Specialists, like those at Elios Clinics, bring their expertise to develop tailored treatment plans, while GPs handle the patient’s routine health needs. This ensures a well-rounded approach to healthcare.
By working together, specialists and GPs offer patients the advantage of expert knowledge in medical cannabis alongside the familiarity and continuity of care that GPs provide. This partnership also promotes clear communication between healthcare providers, ensuring treatments are not only safe but also carefully adjusted to meet each patient’s unique requirements.
What are the differences between accessing medical cannabis treatment through the NHS and private clinics?
Accessing medical cannabis treatment through the NHS can be quite a hurdle. Strict eligibility requirements, a limited number of specialists, and long waiting times often make the process frustrating for patients. Typically, prescriptions are only granted after all other treatment options have been tried and deemed ineffective.
On the other hand, private clinics that focus on medical cannabis care tend to offer a smoother and faster route. These clinics often provide personalised treatment plans, video consultations with GMC-approved doctors, and even next-day delivery for medications. This patient-centred approach can make a significant difference in terms of convenience and care. That said, it’s worth noting that private treatment comes with out-of-pocket expenses, as it is not covered by the NHS.
Related Blog Posts
About author
